These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 14696093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
    Lee MS, Igawa T, Lin MF.
    Oncogene; 2004 Apr 15; 23(17):3048-58. PubMed ID: 14990987
    [Abstract] [Full Text] [Related]

  • 4. Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential.
    Jackson JG, Yoneda T, Clark GM, Yee D.
    Clin Cancer Res; 2000 Mar 15; 6(3):1135-9. PubMed ID: 10741744
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
    Stevenson LE, Frackelton AR.
    Breast Cancer Res Treat; 1998 May 15; 49(2):119-28. PubMed ID: 9696394
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA, Surmacz E.
    Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064
    [Abstract] [Full Text] [Related]

  • 8. p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells.
    Xiao D, Singh SV.
    Cancer Res; 2010 Apr 15; 70(8):3150-8. PubMed ID: 20354186
    [Abstract] [Full Text] [Related]

  • 9. Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.
    Davol PA, Bagdasaryan R, Elfenbein GJ, Maizel AL, Frackelton AR.
    Cancer Res; 2003 Oct 15; 63(20):6772-83. PubMed ID: 14583473
    [Abstract] [Full Text] [Related]

  • 10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 11. Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells.
    Zheng Z, Yang J, Zhao D, Gao D, Yan X, Yao Z, Liu Z, Ma Z.
    FEBS J; 2013 Sep 01; 280(18):4522-30. PubMed ID: 23815759
    [Abstract] [Full Text] [Related]

  • 12. Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factor.
    Gresham J, Margiotta P, Palad AJ, Somers KD, Blackmore PF, Wright GL, Schellhammer PF, Wasilenko WJ.
    Int J Cancer; 1998 Sep 11; 77(6):923-7. PubMed ID: 9714065
    [Abstract] [Full Text] [Related]

  • 13. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens.
    Almeida M, Han L, Ambrogini E, Bartell SM, Manolagas SC.
    Mol Endocrinol; 2010 Oct 11; 24(10):2030-7. PubMed ID: 20685851
    [Abstract] [Full Text] [Related]

  • 14. The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
    Zhang L, Zhu S, Shi X, Sha W.
    Int J Clin Exp Pathol; 2015 Oct 11; 8(8):9097-104. PubMed ID: 26464652
    [Abstract] [Full Text] [Related]

  • 15. Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells.
    Foschi M, Franchi F, Han J, La Villa G, Sorokin A.
    J Biol Chem; 2001 Jul 13; 276(28):26640-7. PubMed ID: 11342545
    [Abstract] [Full Text] [Related]

  • 16. p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.
    Frackelton AR, Lu L, Davol PA, Bagdasaryan R, Hafer LJ, Sgroi DC.
    Breast Cancer Res; 2006 Jul 13; 8(6):R73. PubMed ID: 17196107
    [Abstract] [Full Text] [Related]

  • 17. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 18. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.
    Veeramani S, Chou YW, Lin FC, Muniyan S, Lin FF, Kumar S, Xie Y, Lele SM, Tu Y, Lin MF.
    Free Radic Biol Med; 2012 Jul 01; 53(1):95-108. PubMed ID: 22561705
    [Abstract] [Full Text] [Related]

  • 19. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.
    Alam SM, Rajendran M, Ouyang S, Veeramani S, Zhang L, Lin MF.
    Endocr Relat Cancer; 2009 Mar 01; 16(1):1-16. PubMed ID: 19001530
    [Abstract] [Full Text] [Related]

  • 20. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells.
    Das R, Vonderhaar BK.
    Oncogene; 1996 Sep 19; 13(6):1139-45. PubMed ID: 8808687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.